SRL
HALO icon

Scientech Research LLC’s Halozyme HALO Stock Holding History

Scientech Research LLC’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,830
Closed -$868K – 624
2025
Q3 		$868K Sell
11,830
-31,941
-73% -$2.12M 0.3% 57
2025
Q2 		$2.28M Buy
43,771
+26,238
+150% +$1.49M 0.56% 16
2025
Q1 		$1.12M Buy
17,533
+1,432
+9% +$83.2K 0.3% 69
2024
Q4 		$770K Sell
16,101
-4,050
-20% -$208K 0.22% 177
2024
Q3 		$1.15M Buy
20,151
+312
+2% +$17.9K 0.23% 151
2024
Q2 		$1.04M Buy
19,839
+11,625
+142% +$510K 0.21% 175
2024
Q1 		$334K Buy
+8,214
New +$308K 0.18% 258

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Scientech Research LLC's HALO Position: Q4 2025 in Review

Scientech Research LLC sold out of Halozyme (HALO) in Q4 2025, closing a stake of 11,830 shares — an estimated $868K sold.

Scientech Research LLC first reported a position in HALO in Q1 2024 and held it in 7 quarters. The position peaked at $2.28M in Q2 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Scientech Research LLC reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • Scientech Research LLC sold 11,830 Halozyme shares in Q4 2025, an estimated $868K.
  • Scientech Research LLC first reported a position in Halozyme in Q1 2024 and held it in 7 quarters.
  • Scientech Research LLC's Halozyme position peaked at $2.28M in Q2 2025.
  • 618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.